Ïã¸ÛÁùºÏ²ÊÖÐÌØÍø

XClose

Ïã¸ÛÁùºÏ²ÊÖÐÌØÍø Queen Square Institute of Neurology

Home
Menu

Publications and impact

See also REF 2021 ²¹²Ô»åÌýWhy Study with usÌýfor further examples of research excellence and impact.

REF graphic research power
  • In the calendar year 2023, Institute staff published 1828Ìýpapers; 77Ìýwere published in the top 50 of all scientific journals (ranked by ESI impact factors), including Nature, Science, Lancet ²¹²Ô»åÌýBMJ.Ìý
  • 12Ìýof our professors are named as being among the most influential academics in the worldÌý(Clarivate Web of Science’s ‘Highly Cited Researchers 2022’). Please seeÌýour news itemÌýfor further details.
  • Impact case studiesÌý(from theÌýwebsite)
  • #MadeAtÏã¸ÛÁùºÏ²ÊÖÐÌØÍø campaign ground-breaking research and discoveries

Please see for a list of departmental publications by year. You can also search for specific authors, titles etc within Ïã¸ÛÁùºÏ²ÊÖÐÌØÍø Discovery.ÌýPublication data for individuals within the Department is also available within their

Ìý

Ïã¸ÛÁùºÏ²ÊÖÐÌØÍø ranked as a leader in academic-corporate and academic collaborations inÌýAlzheimer's research

Elsevier has published a new metric for Alzheimer’s research, which finds that Ïã¸ÛÁùºÏ²ÊÖÐÌØÍø is #3 in the world for Alzheimer’s research (2013-2018), while also being a leader in academic-corporate and academic collaborations.ÌýElsevier’s report entitledÌýAlzheimer’s Disease Research Insights: Impact, Trends, OpportunitiesÌýfinds:

  • Ïã¸ÛÁùºÏ²ÊÖÐÌØÍøÌýis amongst the top three global institutions for scholarly output on Alzheimer’s research between 2013-2018, with Harvard University and the Institut National de la Santé et de la Recherche Médicale narrowly above. This makes Ïã¸ÛÁùºÏ²ÊÖÐÌØÍø the leading institution for Alzheimer’s research output in the UK.
  • Globally, Elsevier’s report finds that Ïã¸ÛÁùºÏ²ÊÖÐÌØÍø is the top university for academic-corporate collaborations in Alzheimer’s research, with 15.2% of Ïã¸ÛÁùºÏ²ÊÖÐÌØÍø research involving a corporate.
  • Ïã¸ÛÁùºÏ²ÊÖÐÌØÍø is the second most prolific institution for international academic collaborations (75.7% of Ïã¸ÛÁùºÏ²ÊÖÐÌØÍø’s output of research in Alzheimer’s disease between 2013-2018).

    RAND report shows that Ïã¸ÛÁùºÏ²ÊÖÐÌØÍø has the highest share of highly cited publications in Neurology in England

    An independent report by RAND (2015) which examined highly-cited research, i.e. research publications falling into the top 20% for citations in their year and field, showed that Ïã¸ÛÁùºÏ²ÊÖÐÌØÍø has the highest share of Highly Cited Publications (HCPs) in Neuroimaging (21.1%), Neurosciences (18.1%) andÌýClinical neurology (15.6%) and in the Dementias Highlight Area (15.5%) – in all cases significantly more than the nearest competitor.

    Neuroimaging is one of only two subject areas covered in the analysis where one HEI has over 20% of all HCPs

    Ìý